LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 254 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 10.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $26,254,607 | -24.0% | 438,161 | -8.6% | 2.24% | -10.5% |
| Q2 2023 | $34,568,128 | -2.3% | 479,447 | -0.3% | 2.50% | -2.8% |
| Q1 2023 | $35,368,162 | +109443.0% | 480,807 | -0.5% | 2.57% | +2.1% |
| Q4 2022 | $32,287 | -99.9% | 483,347 | -1.6% | 2.52% | -25.1% |
| Q3 2022 | $42,289,000 | -4.4% | 491,107 | -1.0% | 3.37% | +1.8% |
| Q2 2022 | $44,255,000 | -23.0% | 496,028 | -2.9% | 3.31% | -3.2% |
| Q1 2022 | $57,464,000 | -28.3% | 510,843 | -1.6% | 3.41% | -25.7% |
| Q4 2021 | $80,162,000 | +2.0% | 518,988 | -8.0% | 4.60% | +0.4% |
| Q3 2021 | $78,625,000 | +0.8% | 564,349 | -5.1% | 4.58% | +9.6% |
| Q2 2021 | $77,976,000 | -4.8% | 594,380 | +10.7% | 4.18% | -6.8% |
| Q1 2021 | $81,869,000 | +28.2% | 537,028 | -16.4% | 4.48% | +16.2% |
| Q4 2020 | $63,854,000 | +1.0% | 642,073 | -3.2% | 3.85% | -9.4% |
| Q3 2020 | $63,233,000 | -12.7% | 663,383 | +2.4% | 4.25% | -18.1% |
| Q2 2020 | $72,441,000 | +56.7% | 647,668 | +1.9% | 5.19% | +31.7% |
| Q1 2020 | $46,232,000 | – | 635,758 | – | 3.94% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KNOTT DAVID M | 353,041 | $36,819,000 | 14.92% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 919,994 | $95,946,000 | 2.93% |
| Elk Creek Partners, LLC | 236,862 | $24,702,000 | 2.84% |
| Conestoga Capital Advisors, LLC | 619,653 | $64,624,000 | 1.56% |
| WOODSTOCK CORP | 71,489 | $7,456,000 | 1.21% |
| Summit Creek Advisors LLC | 70,962 | $7,401,000 | 1.16% |
| FALCON POINT CAPITAL, LLC | 8,115 | $846,000 | 1.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 302,503 | $31,548,000 | 1.07% |
| Stephens Investment Management Group LLC | 508,100 | $52,990,000 | 1.00% |
| Tygh Capital Management, Inc. | 55,672 | $5,806,000 | 0.96% |